Hepatitis C patients found to require lesser drugs for treatment

New Treatment for Multiple Sclerosis
March 30, 2016
Don’t tell cancer patients what they could be doing to cure themselves
March 31, 2016
Show all

Hepatitis C patients found to require lesser drugs for treatment

It might be possible to cure hepatitis C in a shorter time, which would also save patients a lot of money.

Using less drugs against hepatitis C is healthier and significantly cheaper for nearly half of the patients, according to a study.

Since hepatitis C patients are often cured before completing a treatment regimen, researchers at Loyola University noted that less of the drugs is needed to fight the disease.

Treatment cost for the average patient would go down by 16 to 20 percent, and as much as 50 percent for 40 percent of the patients.

The researchers at Loyola University devised a computation that predicts the length of time patients need direct-acting antiviral drugs. Using more frequent blood testing, the researchers were able to determine hepatitis C levels and predict when the drug sofosbuvir, combined with one of three others, could be stopped.

Dr. Scott Cotler, a professor at Loyola University, pointed out that treatment is currently standardized for a set period of time, not tailored to the patient, according to a report by UPI. Cotler added that in many cases there was a prolonged use of expensive drugs with essentially no additional positive effect.

Read Full Article: Hepatitis C patients found to require lesser drugs for treatment

 

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.